HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,532 | -41.1% | 22,847 | -33.7% | 0.00% | – |
Q2 2023 | $39,955 | -81.4% | 34,444 | -75.8% | 0.00% | – |
Q1 2023 | $215,192 | -34.1% | 142,511 | +9.1% | 0.00% | -100.0% |
Q4 2022 | $326,603 | -45.7% | 130,641 | -8.4% | 0.00% | 0.0% |
Q3 2022 | $602,000 | +65.4% | 142,681 | +9.3% | 0.00% | 0.0% |
Q2 2022 | $364,000 | -48.4% | 130,569 | +6.0% | 0.00% | 0.0% |
Q1 2022 | $705,000 | -41.3% | 123,171 | -6.5% | 0.00% | 0.0% |
Q4 2021 | $1,202,000 | -12.9% | 131,666 | +2.0% | 0.00% | -50.0% |
Q3 2021 | $1,380,000 | -30.2% | 129,071 | +1.3% | 0.00% | 0.0% |
Q2 2021 | $1,977,000 | -7.7% | 127,394 | -3.6% | 0.00% | -33.3% |
Q1 2021 | $2,142,000 | -23.6% | 132,138 | -0.3% | 0.00% | -25.0% |
Q4 2020 | $2,804,000 | +42.8% | 132,486 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $1,963,000 | +1.0% | 132,486 | +0.3% | 0.00% | 0.0% |
Q2 2020 | $1,944,000 | +29.6% | 132,122 | +3.4% | 0.00% | 0.0% |
Q1 2020 | $1,500,000 | -50.3% | 127,751 | -0.5% | 0.00% | -40.0% |
Q4 2019 | $3,017,000 | +41.8% | 128,385 | +11.6% | 0.01% | +25.0% |
Q3 2019 | $2,128,000 | +0.8% | 115,007 | +1.2% | 0.00% | 0.0% |
Q2 2019 | $2,112,000 | -18.1% | 113,631 | +7.7% | 0.00% | -20.0% |
Q1 2019 | $2,579,000 | -7.9% | 105,542 | -2.2% | 0.01% | -16.7% |
Q4 2018 | $2,799,000 | -16.1% | 107,888 | +2.3% | 0.01% | 0.0% |
Q3 2018 | $3,338,000 | -12.0% | 105,455 | +8.0% | 0.01% | -25.0% |
Q2 2018 | $3,793,000 | +66.2% | 97,644 | +18.1% | 0.01% | +60.0% |
Q1 2018 | $2,282,000 | +76.1% | 82,695 | +15.5% | 0.01% | +66.7% |
Q4 2017 | $1,296,000 | +10.5% | 71,613 | -1.4% | 0.00% | 0.0% |
Q3 2017 | $1,173,000 | +5.2% | 72,611 | -9.8% | 0.00% | +50.0% |
Q2 2017 | $1,115,000 | -9.9% | 80,532 | -2.4% | 0.00% | -33.3% |
Q1 2017 | $1,238,000 | +44.3% | 82,532 | +25.9% | 0.00% | +50.0% |
Q4 2016 | $858,000 | -26.0% | 65,532 | -2.7% | 0.00% | 0.0% |
Q3 2016 | $1,160,000 | -3.6% | 67,332 | +1.1% | 0.00% | -33.3% |
Q2 2016 | $1,203,000 | +2.4% | 66,632 | +7.6% | 0.00% | 0.0% |
Q1 2016 | $1,175,000 | -18.8% | 61,900 | +14.2% | 0.00% | -25.0% |
Q4 2015 | $1,447,000 | +11.5% | 54,211 | +1.9% | 0.00% | +33.3% |
Q3 2015 | $1,298,000 | -7.5% | 53,211 | +18.2% | 0.00% | 0.0% |
Q2 2015 | $1,403,000 | +127.0% | 45,011 | +5.9% | 0.00% | +200.0% |
Q1 2015 | $618,000 | +43.1% | 42,488 | -1.2% | 0.00% | 0.0% |
Q4 2014 | $432,000 | +21.0% | 42,988 | +0.4% | 0.00% | 0.0% |
Q3 2014 | $357,000 | -18.3% | 42,804 | +20.6% | 0.00% | 0.0% |
Q2 2014 | $437,000 | – | 35,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |